Tang, S., Long, X., Li, F., Jiang, S., Fu, Y., & Liu, J. Identification of RUVBL2 as a novel biomarker to predict the prognosis and drug sensitivity in multiple myeloma based on ferroptosis genes. Taylor & Francis Group.
Chicago Style (17th ed.) CitationTang, Sishi, Xinyi Long, Fangfang Li, Siyi Jiang, Yunfeng Fu, and Jing Liu. Identification of RUVBL2 as a Novel Biomarker to Predict the Prognosis and Drug Sensitivity in Multiple Myeloma Based on Ferroptosis Genes. Taylor & Francis Group.
MLA (9th ed.) CitationTang, Sishi, et al. Identification of RUVBL2 as a Novel Biomarker to Predict the Prognosis and Drug Sensitivity in Multiple Myeloma Based on Ferroptosis Genes. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.